- In This Issue on 11-November-2024
-
Yoo JH
- KMID: 2561432
- J Korean Med Sci.
- 2024 Nov;39(43):e325.
- doi: 10.3346/jkms.2024.39.e325
-
- CITED
-
- Close
- SHARE
-
- Close
- Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea
-
Park B, Lee HA, Kim Y, Kim CH, Park H, Jun S, Lee H, Kwon SL, Heo Y, Lee H, Park H
- KMID: 2561430
- J Korean Med Sci.
- 2024 Nov;39(43):e309.
- doi: 10.3346/jkms.2024.39.e309
The emergence of the omicron variant and its sub-lineages has necessitated vaccine updates for coronavirus disease 2019. In September 2023, the U.S. Food and Drug Administration approved an updated BNT162b2... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Early Continuous Kidney Replacement Therapy in Patients With Sepsis-Associated Acute Kidney Injury: An Analysis of the MIMIC-IV Database
-
Lee Y, Seo JH, Seong J, Ahn SM, Han M, Lee JA, Kim JH, Ahn JY, Jeong SJ, Choi JY, Yeom JS, Oh HJ, Ku NS
- KMID: 2561427
- J Korean Med Sci.
- 2024 Nov;39(43):e276.
- doi: 10.3346/jkms.2024.39.e276
Background: Renal replacement therapy (RRT) is an important treatment option for sepsisassociated acute kidney injury (AKI); however, the optimal timing for its initiation remains controversial. Herein, we investigated the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Manifestations in Patients on Hemodialysis and Assessment of the Changes in Quality of Life After 12 Weeks of Treatment by a Dermatologist
-
Jeong JS, Lee Y, Lee S, Baek H, Choi MJ, Her Y, Park JI
- KMID: 2561429
- J Korean Med Sci.
- 2024 Nov;39(43):e280.
- doi: 10.3346/jkms.2024.39.e280
Background: Cutaneous manifestations are frequently observed in end-stage kidney disease (ESKD) and affect the quality of life (QoL) of patients undergoing maintenance hemodialysis (HD). Even patients undergoing HD who frequently... -
- CITED
-
- Close
- SHARE
-
- Close
- FGFR Inhibitors in Urothelial Cancer: From Scientific Rationale to Clinical Development
-
Kwon WA
- KMID: 2561431
- J Korean Med Sci.
- 2024 Nov;39(43):e320.
- doi: 10.3346/jkms.2024.39.e320
In the past decade, the treatment of metastatic urothelial cancer (mUC), including bladder cancer (BC), has transformed significantly with the introduction of diverse therapies, such as immune checkpoint inhibitors, targeted... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Palivizumab in Preventing Severe Acute Lower Respiratory Infection in Moderate-to-Late Preterm Infants: A Nationwide Cohort Study
-
Kim S, Choe YJ, Lee S, Heo JS
- KMID: 2561428
- J Korean Med Sci.
- 2024 Nov;39(43):e279.
- doi: 10.3346/jkms.2024.39.e279
Background: Respiratory syncytial virus (RSV) prophylaxis using palivizumab effectively reduces RSV-associated morbidity in preterm infants. In Korea, national insurance coverage for palivizumab was implemented in October 2016 for moderate-to-late preterm... -
- CITED
-
- Close
- SHARE
-
- Close
